Patents by Inventor Sean N. Tucker

Sean N. Tucker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8999946
    Abstract: The present invention provides chimeric adenoviral vectors and methods for using the vectors to elicit an immune response to an antigen of interest.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: April 7, 2015
    Assignee: Vaxart, Inc.
    Inventor: Sean N. Tucker
  • Publication number: 20130164326
    Abstract: The present invention provides chimeric adenoviral vectors and methods for using the vectors to elicit an immune response to an antigen of interest.
    Type: Application
    Filed: June 25, 2012
    Publication date: June 27, 2013
    Applicant: Vaxart, Inc.
    Inventor: Sean N. Tucker
  • Publication number: 20120244185
    Abstract: The invention provides chimeric viral expression vectors and method of use for providing an immune response against H1N1 influenza. The compositions of the invention can be used as vaccines for H1N1 strains. Advantages include rapid development and availability once a strain is isolated, and effective oral or mucosal administration.
    Type: Application
    Filed: September 15, 2010
    Publication date: September 27, 2012
    Applicant: Vaxart ,Inc.
    Inventors: Sean N. Tucker, Ciaran Scallan
  • Patent number: 8222224
    Abstract: The present invention provides chimeric adenoviral vectors and methods for using the vectors to elicit an immune response to an antigen of interest.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: July 17, 2012
    Assignee: Vaxart, Inc.
    Inventor: Sean N. Tucker
  • Publication number: 20110081375
    Abstract: The present invention provides chimeric adenoviral vectors and methods for using the vectors to elicit an immune response to an antigen of interest.
    Type: Application
    Filed: November 12, 2010
    Publication date: April 7, 2011
    Applicant: Vaxart, Inc.
    Inventor: Sean N. Tucker
  • Patent number: 7879602
    Abstract: The present invention provides chimeric adenoviral vectors and methods for using the vectors to elicit an immune response to an antigen of interest.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: February 1, 2011
    Assignee: Vaxart, Inc.
    Inventor: Sean N. Tucker